FRA:VME (Germany)
Â
Registered Shares
€
6.8
+0.050 (+0.74%)
Jul 2
Business Description
Viromed Medical AG
ISIN : DE000A40ZVN7
Share Class Description:
FRA:VME: Registered SharesDescription
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 40.44 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 24.52 | |||||
Beneish M-Score | 0.85 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Book Growth Rate | -20.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.8 | |||||
9-Day RSI | 45.92 | |||||
14-Day RSI | 49.27 | |||||
3-1 Month Momentum % | 39.22 | |||||
6-1 Month Momentum % | 87.83 | |||||
12-1 Month Momentum % | 62.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.74 | |||||
Quick Ratio | 2.39 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 70.93 | |||||
Days Sales Outstanding | 36.16 | |||||
Days Payable | 115.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.6 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 44.92 | |||||
Operating Margin % | -16.95 | |||||
Net Margin % | 11.89 | |||||
EBITDA Margin % | -10.5 | |||||
ROE % | 4.51 | |||||
ROA % | 3.73 | |||||
ROIC % | -5.82 | |||||
ROC (Joel Greenblatt) % | -9.76 | |||||
ROCE % | -3.74 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 242.86 | |||||
PE Ratio without NRI | 242.86 | |||||
PS Ratio | 28.45 | |||||
PB Ratio | 13.79 | |||||
Price-to-Tangible-Book | 18.38 | |||||
EV-to-EBIT | -269.93 | |||||
EV-to-EBITDA | -269.93 | |||||
EV-to-Revenue | 28.34 | |||||
Price-to-Graham-Number | 14.17 | |||||
| Price-to-Net-Current-Asset-Value | 61.82 | |||||
Earnings Yield (Greenblatt) % | -0.37 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Viromed Medical AG Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5.087 | ||
| EPS (TTM) (€) | 0.028 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 97.17 | ||
| 14-Day RSI | 49.27 | ||
| 14-Day ATR (€) | 0.208633 | ||
| 20-Day SMA (€) | 6.93 | ||
| 12-1 Month Momentum % | 62.84 | ||
| 52-Week Range (€) | 3 - 8.3 | ||
| Shares Outstanding (Mil) | 21.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Viromed Medical AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Viromed Medical AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Viromed Medical AG Frequently Asked Questions
What is Viromed Medical AG(FRA:VME)'s stock price today?
The current price of FRA:VME is €6.80. The 52 week high of FRA:VME is €8.30 and 52 week low is €3.00.
When is next earnings date of Viromed Medical AG(FRA:VME)?
The next earnings date of Viromed Medical AG(FRA:VME) is .
Does Viromed Medical AG(FRA:VME) pay dividends? If so, how much?
Viromed Medical AG(FRA:VME) does not pay dividend.
Press Release
Articles on Viromed Medical AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers